Page last updated: 2024-08-16

raloxifene and pd 0325901

raloxifene has been researched along with pd 0325901 in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Beerli, R; Blanz, J; Drückes, P; Fendrich, G; Gassmann, E; Glatthar, R; Gutmann, S; Hornfeld, J; Martiny-Baron, G; Mattes, H; Möbitz, H; Peel, JE; Sparrer, H; Spence, F; Stojanovic, A; Troxler, T1

Other Studies

1 other study(ies) available for raloxifene and pd 0325901

ArticleYear
Discovery of Imidazoquinolines as a Novel Class of Potent, Selective, and in Vivo Efficacious Cancer Osaka Thyroid (COT) Kinase Inhibitors.
    Journal of medicinal chemistry, 2016, 08-25, Volume: 59, Issue:16

    Topics: Animals; Crystallography, X-Ray; Dogs; Dose-Response Relationship, Drug; Drug Discovery; Humans; Imidazoles; Male; MAP Kinase Kinase Kinases; Models, Molecular; Molecular Structure; Protein Kinase Inhibitors; Proto-Oncogene Proteins; Quinolines; Rats; Rats, Sprague-Dawley; Structure-Activity Relationship; Tumor Necrosis Factor-alpha

2016